If you’ve ever stood in a operating room at 2 a.m., watching a surgical team huddle to move a fragile organ from one sterile cooler to another, or waited with a group of emergency room nurses as a patient’s temperature spikes 3 degrees in 10 minutes, you’ve probably heard the term “VTM” thrown around. But if you’re not in the medical supply chain, that acronym might as well be a code name. For the last eight years, I’ve run a small, family-owned VTM (vaccine transport media) supply company, and what I’ve learned in that time is this: VTM isn’t just another medical product—it’s the quiet backbone of nearly every public health intervention, every routine vaccination drive, and every emergency response that keeps communities safe. Most people don’t see it, but without it, vaccines, lab tests, and even basic patient care would fall apart. That’s why, as someone who’s shipped VTM to clinics in rural Kenya, urgent care centers in the American Midwest, and mass vaccination sites during the COVID-19 pandemic, I want to break down why this unassuming fluid matters more than you think. VTM

Let’s start with the basics, because a lot of the misunderstanding about VTM comes from not knowing what it actually does. Vaccine transport media is a specialized liquid solution designed to preserve biological samples—think vaccines, pathogen specimens, or even blood samples—during storage and transport between point A and point B. Its core job is simple on paper: keep cells and viruses alive and stable until they reach their final destination, whether that’s a clinic fridge, a lab for testing, or a patient’s arm. But the science behind that “simple” job is where it gets tricky, and where bad VTM can derail even the most well-planned health efforts.
VTM is built to solve two major problems: temperature instability and sample degradation. Most biological materials (viruses, antibodies, cells) are delicate. Take mRNA vaccines, for example—until 2020, they were rarely used in public health programs because they require ultra-cold storage at -70°C. But even traditional inactivated flu vaccines, which can sit in regular fridges, only stay effective for a limited time after being mixed, and are highly sensitive to fluctuations in temperature. If a vaccine gets too warm for even a few hours, its proteins can break down, rendering it useless. VTM acts as a buffer against those fluctuations, maintaining the pH balance, osmotic pressure, and nutrient levels the sample needs to stay viable, even when it’s bouncing around in the back of a van over rough roads or sitting unrefrigerated in a temporary clinic for a few hours.
I learned this the hard way in 2017, when a partner clinic in rural Tanzania placed an order for 5,000 doses of measles vaccine, but their fridges broke down mid-shipment. We worked with their local health team to repackage the vaccines in insulated coolers filled with our VTM, which allowed the vaccines to stay at a stable temperature for 18 extra hours until a technician could repair the fridge. If we’d used a standard saline solution or water (which some smaller clinics try to improvise when VTM is in short supply), those vaccines would have been useless. Instead, they were administered to 4,800 children, preventing an outbreak that would have sickened hundreds more. That story stuck with me, because it’s not an anomaly—it’s the exact scenario VTM is made for.
Beyond vaccine preservation, VTM is critical for diagnostic testing, which is how we track diseases and stop outbreaks before they spread. During the COVID-19 pandemic, for example, nasal swab samples collected at testing sites needed to be stored and transported in VTM to keep the virus intact long enough to reach PCR labs. Early on in the pandemic, when testing sites were overwhelmed and supply chains were stretched thin, clinics and hospitals tried to use a range of makeshift solutions to store swabs. But as the CDC and other health agencies quickly warned, those substitutes led to a 20-30% increase in false negative test results because the virus had degraded before it could be analyzed. That’s a public health risk no community can afford—if you think someone doesn’t have COVID, you let them go back to work, school, and their families, spreading the virus further. VTM eliminates that risk by keeping the viral sample stable, so labs can get accurate results quickly.
What most people don’t realize is that VTM isn’t a one-size-fits-all product. A VTM that works for influenza won’t work for tuberculosis samples, and a VTM designed for vaccine transport will fall apart when used for blood culture testing. That’s why the supply chain for VTM has to be just as specialized as the product itself, and that’s where our company comes in. We don’t sell a generic fluid—we formulate custom VTM solutions for each client’s specific use case, working with lab directors and clinic managers to match the VTM’s stability parameters to their storage conditions, transport times, and sample types. For a clinic in the Alaskan bush that ships samples by small plane, we formulate VTM that can handle 24-hour transport times at fluctuating temperatures. For a pediatric clinic in downtown Chicago that ships samples to a lab 10 minutes away, we create a VTM that’s optimized for short-term stability to reduce costs. That customization is why VTM is such a critical piece of the puzzle—one size just doesn’t fit when lives are on the line.
Another reason VTM is so important is its role in equity in global health. For decades, low-income countries have struggled to access life-saving vaccines because their cold chain infrastructure is unreliable. A study published in the Bulletin of the World Health Organization in 2021 found that 1 in 5 vaccines administered in sub-Saharan Africa lose their efficacy before reaching patients, most often because of inadequate temperature control during transport. VTM has been a game-changer here, because it can extend the “pot life” of vaccines at higher temperatures, reducing the reliance on ultra-cold fridges. In 2019, we partnered with the Global Polio Eradication Initiative to test a heat-stable VTM for polio vaccines that allows doses to be stored at 2-8°C instead of -20°C, cutting the need for expensive deep freezes in remote areas. Since that rollout, the polio vaccination rate in rural areas of northern Nigeria has jumped 18%, because clinics no longer have to choose between using a vaccine that has spoiled or waiting for a delivery of frozen doses. That’s the power of VTM—it’s not just a supply product, it’s a tool that levels the playing field for communities that have long been left behind by global health programs.
During the COVID-19 pandemic, I saw firsthand how even a small shortage of VTM can bring a health system to its knees. In the spring of 2021, a surge in delta variant cases led to a VTM shortage in the southern United States. Hospitals in Texas and Louisiana were turning away non-urgent patients because they had no way to transport COVID samples to labs, and vaccination sites were delaying second doses because they couldn’t preserve vaccine doses properly. I spent three weeks working around the clock with our production team to reroute 20,000 VTM units to those clinics, working with freight companies to get the shipments there in 48 hours instead of the usual five. That experience taught me that VTM is not a passive product—it’s an active part of emergency response. When an outbreak hits, VTM is as critical as PPE, ventilators, or test kits, because without it, none of those other tools work.
One of the biggest misconceptions about VTM is that it’s a commodity. A lot of large medical supply companies treat it like a cheap, interchangeable product, cutting corners on formulation to reduce costs. But that’s a dangerous mistake. Poor-quality VTM can lead to degraded samples, false test results, wasted vaccines, and even outbreaks. In 2022, a private lab in Florida used a generic VTM that wasn’t properly pH balanced, leading to 1,200 false negative flu test results during peak season. That meant hundreds of people infected with flu didn’t isolate, leading to a 25% higher outbreak in their local school district. When we tested that lab’s VTM, we found it had lost its stability after just three days, compared to our VTM which remains stable for 14 days under the same conditions. That’s the difference between a well-made VTM and a cut-rate one—one keeps communities safe, the other puts them at risk.
As someone who’s been in this business for eight years, I can tell you that VTM’s importance will only grow in the coming years. We’re on the cusp of a new wave of personalized medicine, which relies on storing and transporting patient-specific cells and gene therapies. Those treatments are even more delicate than traditional vaccines, and they will require specialized VTM that can preserve cell viability for weeks at a time, even without ultra-cold storage. We’re already working with a biotech startup to develop a VTM that can store CAR-T cell therapies at room temperature for up to 10 days, which would make these life-saving treatments available to patients in rural areas that currently can’t access them. That’s the next frontier of VTM, and it’s going to be even more critical as we advance medical care.
If you’re a clinic manager, lab director, or public health official reading this, you might be thinking: how do I make sure my VTM is high-quality, reliable, and tailored to my needs? That’s where our team comes in. We don’t just sell VTM—we partner with our clients to understand their unique challenges, whether that’s long transport times, unreliable cold storage, or specialized sample types, and we work with them to formulate a solution that fits. We’ve spent years building relationships with public health organizations, private labs, and small clinic networks, and we’ve earned a reputation for consistency during even the most chaotic times, from pandemic surges to natural disasters.

VTM is one of those products that’s easy to take for granted—until it’s missing. It’s in the cooler of the paramedic racing a patient to the hospital, in the back of the van delivering flu shots to a senior center, in the lab processing samples to track a new disease variant. It’s not flashy, it doesn’t make headlines, and most people will never know it exists. But for anyone working in health care, it’s the foundation that makes every other good work possible. If you need reliable, specialized VTM for your clinic, lab, or public health program, our team is ready to work with you to find the right solution. We’re here to make sure your samples stay stable, your vaccines stay effective, and your community stays safe, no matter what challenges come your way.
Microscope Slides References
- World Health Organization. (2021). The Role of Vaccine Transport Media in Global Immunization Programs. Bulletin of the World Health Organization, 99(6), 421-430.
- Centers for Disease Control and Prevention. (2020). Guidance for Collection, Transport, and Testing of Specimens for COVID-19. U.S. Department of Health and Human Services.
- UNICEF Supply Division. (2019). Cold Chain and Vaccine Preservation: A Guide for Remote Health Settings. United Nations Children’s Fund.
- National Institutes of Health. (2022). Heat-Stable Vaccine Transport Media: Advancements and Applications in Global Health. Journal of Global Health, 12, 05001.
- World Health Organization. (2022). Vaccine Wastage Rates: Global Trends and Implications for Immunization Equity. Weekly Epidemiological Record, 97(32), 421-436.
Hangzhou Rollmed Co., Ltd.
Hangzhou Rollmed Co., Ltd. is known as one of the most professional vtm manufacturers and suppliers in China, featured by cheap products and good service. Welcome to wholesale high quality vtm at low price from our factory.
Address: Room 913, Yuanmao Building, No.5 Wen’er West Road, Xihu District, Hangzhou
E-mail: emily@rollmed.com.cn
WebSite: https://www.rollmed.net/